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Abstract: Objective: To study the effectiveness and safety of bilateral uterine artery occlusion through the vaginal 
approach as an alternative treatment modality for symptomatic uterine myomas. 
Methods: Sixty-nine premenopausal women with symptomatic uterine leiomyomata were studied. None of them desired 
further pregnancy underwent bilateral vaginal uterine arteries occlusion. The primary outcome measures were patient 
satisfaction as regards menstrual blood loss compared with pre treatment loss and operative duration. Secondary 
outcome measures included postoperative pain, complications, secondary interventions, and failures. 
Results: Sixty-three women were completed follow up till 24 months after the procedure. The primary outcomes were 
encouraging as regards patient satisfaction for post treatment blood loss (90.7 %) and mean operative duration ( 35 ±9.5 
minutes). After 6 months of follow-up, 6 patients resumed heavy periods and interventions needs secondary. 
Conclusion: Trans-vaginal occlusion of uterine arteries improved clinical symptoms in the majority of patients.  
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INTRODUCTION 
Uterine leiomyomata are among the most frequent 
entities encountered in the practice of gynecology. 
Uterine fibroids occur in 20% to 40% of reproductive 
age women and are the most common solid pelvic 
tumors in women [1, 2]. Even though most fibroids are 
benign and asymptomatic, some patients may 
complain of abnormal uterine bleeding, pelvic pressure, 
infertility, and recurrent pregnancy loss. These 
symptoms may have a negative effect on a patient’s 
physical, emotional, and social well-being [3]. 
Fibroids are the main indication for 40% to 50% of 
hysterectomies [4, 5]. Adverse events associated with 
hysterectomy include significant blood loss, venous 
thromboembolism, infection, injury to bladder, bowel, or 
major blood vessels, and death [6]. 
Over the last few decades, trends in gynaecology 
have been towards conservative or minimally invasive 
therapies for common conditions, including exploring 
alternatives to hysterectomy or myomectomy for 
symptomatic-fibroids through a critical evaluation of 
three  
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treatment options: global endometrial ablation, uterine 
fibroid devascularisation, and magnetic resonance-
guided focused ultrasound [7]. 
Magnetic resonance-guided focused ultrasound 
(MRgFUS) is a totally non-invasive surgical approach 
for the treatment of symptomatic uterine  
Fibroids It utilizes precisely focused ultrasound 
waves to generate and maintain temperatures in 
excess of 56°C within the target tissue, resulting in 
protein denaturation, cell death and coagulative 
necrosis [3]. Although clinical studies demonstrate that 
MRgFUS is a safe, effective treatment for symptomatic 
uterine fibroids, can be performed as an outpatient 
procedure; requires no general anesthesia [8], and is 
cost effective [9]. However not all patients are 
candidates for the procedure [10] and not free from 
complications-not [11]. 
Selective uterine artery occlusion is a global treat- 
ment alternative to hysterectomy for women with symp- 
tomatic uterine fibroids, in whom other medical and sur- 
gical treatments are contra-indicated, refused, or ineffe- 
ctive [12]. Fibroids have been treated effectively by lap- 
aroscopic occlusion at the origin of the uterine arteries 
using vascular clips [13] or bipolar electrocoagulation [14]  
Since the uterine arteries are located less than 2 cm 
away from the vaginal lateral fornices, transvaginal 
uterine occlusion by surgery or colour Doppler-directed 
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ultrasonic probe appears feasible [15,16]. Transvaginal 
occlusion of the uterine arteries is performed by placing 
specially designed clamps in the vaginal fornices and, 
guided by Doppler ultrasound auditory signals, posi- 
tioning it to occlude the uterine arteries. The clamps are 
left in place for 6 hours and then removed. Results are 
preliminary, but this technique may develop into an 
alternative, noninvasive method for decreasing myoma 
size [15, 16]. 
So, our study aims to evaluate the effectiveness 
and feasibility of surgical transvaginal bilateral uterine 
arteries ligation in management of symptomatic uterine 
myomas as an effective alternative in low resourse 
settings. 
MATERIALS AND METHODS 
The study was carried out at the Department of 
Gynecology, Mansoura University, Egypt. Sixty nine 
(69) premenopausal women referred with abnormal 
uterine bleeding between March 2009 and March 2011 
were included in this trial. Inclusion criteria included 
women with uterine fibroids causing abnormal uterine 
bleeding with desire not to have a hysterectomy. 
Exclusion criteria included pregnancy,a history of deep 
vein thrombosis, hematocrit < 25%, one or more lower 
uterine segment fibroids, a history of gynaecologic 
malignancy or atypical endometrial hyperplasia, active 
pelvic inflammatory disease or infection, acute or 
chronic systemic infection,GnRH agonist use in the 
preceding six months, current use of an anticoagulant, 
bleeding disorder, severe hematologic or neurologic 
disease, prior endometrial ablation, prior Uterine Artery 
Embolization (UAE) or prior Uterine Artery Ligation 
(UAL), only women with fibroids located above the 
uterine arteries and not distorting the cervix were 
included in the study. Suspicion of malignancy (by 
endometrial sampling and cervical cytology) , 
submucous leiomyomata with an intracavitary 
extension of more than 50% (more suitable for 
hysteroscopic resection) were rulled out. All eligible 
patients attended a consultation by a gynaecologist, 
which included a gynaecological examination, 
ultrasonography, routine endometrial samplig; cervical 
cytology and office hysteroscopy in suspected uterine 
cavity lesion(s). Patients were informed about the 
possible risks and benefits of the treatment and a 
written consent was obtained from each patient. The 
study was approved by the local research ethics 
committee. The procedure was carried out in the 
operating theatre with the patient placed in lithotomy 
position under regional or general anaesthia. Vaginal 
wall retractors were placed allowing visualization of the 
vaginal fornices and the cervix which was exposed and 
grasped with a tenaculum. Gentle traction on the cervix 
was done then the vesico-cervical space was opened 
and the urinary bladder mobilised up. Then the right 
lateral vaginal fornix was opened. 1- 1.5 cm incision 
was done in the medial lower border of the right 
Mackenrodts ligament and the right  uterine artery was 
identified and skeletonised from the ureter and then a 
double ligature by aneurysm needle were passed to 
ligate the uterine artery using poly galactine number 1 
vicryl sutures [ETHICON® ltd uk]. Then the procedure 
was carried on the left side with the same manner on 
the right one. The Ruta Menorrhagia Severity Scale 
[17] that allows the patient to assess her own menstrual 
experience from the preceding three months was used. 
Low scores indicate a higher quality of life [17]. The 
participants were encouraged to use the same type of 
sanitary pads during the study period. The study 
participants were surveyed in relation to their present 
leiomyoma-related symptoms before treatment and 
after 1, 3, 6, 12 and 24 months, respectively. Clinical 
failure was defined as persisting symptoms requiring 
secondary treatment or no improvement at the 6-month 
follow-up. Postoperative pain and nausea during the 
hospital stay were recorded on post operative charts. 
The resident doctors were asked to fill in the level of 
pain and nausea patients experienced every 4 hours 
during the first 24 hours in the hospital and every 6 
hours during the next 24 hours or until the patient left 
the hospital. The analgesic regimen consisted of 
nonsteroidal anti-inflammatory drugs and paracetamol-
codeine combination in fixed doses. Adverse events 
were also recorded for each patient during the hospital 
stay and during outpatient visits after 1, 3, 6, 12 and 24 
months. All subsequent surgical and medical 
interventions, as well as readmission to the hospital or 
prolonged hospitalization were recorded as adverse 
events. Clinical failure was defined as persistent 
symptoms requiring secondary treatment or no 
improvement at the 6-month follow-up. Doppler study 
of uterine arteries was done 48 hours after the 
procedure for all participants. Statistical analysis was 
performed with SPSS 16.0 (Chicago, IL), and the data 
are presented as mean values for normal distributed 
data and as median values for skewed data. A 
significance level of 0.05 was used for all tests. Power 
of the study and sample size was acheived using 
PASS 2008 (Power analysis and sample size, NCSS, 
Kaysville, UT, USA). So, a sample size of 69 patients, 
giving a power of 93 % (18, 19). 
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RESULTS  
This study includes sixty nine patients all underwent 
bilateral vaginal occlusion of main uterine arteries and 
they were followed up for 3, 6; 12 and 24 months for 
the improvement of the symptoms. Only sixty- three 
patients completed the 24 months follow up. 
Demographic criteria of the studied group listed in 
Table 1 showing that the mean age of the studied 
group was 49 years  ± 4.5 SD , the mean parity was 4 ± 
2.2 SD, BMI was 24 ± 3.15 SD, myoma numbers were 
4 ± 2.9 SD; myoma(s) volume 122 ±72.3 SD ml and 
uterine volume 233 ± 98.4 SD ml. Table 2 reporting the  
Table 1: Demographic Characteristics of the Study 
Group 
Mean ± SD Total Number (69) Characteristics 
 
49 ± 4.5 
 
11 (15.9%) 
37 (53.6 %) 
21 (30.5 %) 
Age  
35 years 
35-45 years 
45 years 
 
4 ± 2.2 
 
9 (13.1 %  
43 (62.3 %) 
17 (24.6 %) 
Parity 
0–2 
2-5 
 5 
 
24 ± 3.15 
 
38 (55 %) 
21 (30.5 %) 
10 (14.5 %) 
BMI 
19–24 
25-29 
29 
 4± 2.9 Number of myomas 
 122 ±72.3 Size of myoma(s) / ml 
 233 ± 98.4 Volume of the uterus /ml 
Table 2: Postoperative Complications and Analgesia 
Administration in the Study Group 
Total Number (69 = 100 %) Operative Complications and 
Postoperative Analgesia Given 
 
66 (95.6 %) 
3 (4.4 %) 
0 (0.0 %) 
Complications:- 
No Complication 
Bladder injury 
Ureteric injury  
 
23 (33.3%) 
37 (53.6%) 
9 (13.1%) 
Post operative analgesia 
Placebo 
NSAID 
NSAID + morphine 
post operative complications and needs of post 
operative analgesia. Only three cases (3/69) 4% had 
bladder injury and corrected immediatly intra operative 
and nine patients (9/69) 13.1% needs non steroidal anti 
inflamatory Drugs (NSAID) + morphine. Blood loss and 
operative duration were listed in Table 3 showing that 
mean operative time was 35  ± 9.5 minutes and only 
three patients (3/69) 4% needed blood transfusion. 
Clinical outcomes after follow up for 3, 6, 12 and 24 
months were studied in Table 4 showing greet 
improvement of the symptoms with 90.7 % reduction in 
bleeding, 81 % improvement in pelvic pressure, 83 % 
improvement in dysmenorrhea; 88 % relief of all 
symptoms and 90 % over all satisfaction  after 24 
months follow up. Clinical failure occur in six cases 
after six months follow up needing hysterectomy. 
Table 3: Average Duration of Operation and Blood Loss 
in the Study Group 
Outcomes Total 
Operative Duration / Minutes 35 ± 9.5 Minutes 
Blood loss 
Mild (150 ml) 
Moderate (150- 300 ml) 
Severe (300 ml) 
Needs of blood transfusion 
 
63 (91.3%) 
4 (5.8 %) 
2 (2.9 %) 
3 (4.3 %) 
DISCUSSION  
Although with the advent of the science and 
technologies which approved by Food and Drug 
Association in the field of minimally invasive surgery 
and its effectiveness like myolysis, UAE, UAL, Uterine 
Artery Coagulation (UAC); MRgFUS and transvaginal 
incisionless doppler guided temporary uterine artery 
occlusion in management of symptomatic fibroids 
[8,13-16, 20]. These are not suitable for low resource 
settings. So, we did our study and compared our 
results with other studies as regards improvement of 
myoma related symptoms and patient satisfaction as a 
primary goal. In our study there  was improvement in all 
myoma related symptoms and patient satisfaction at 
the six- month follow up there is improvement in 
bleedig by 84%, pelvic pressure by 57%, pelvic pain by 
59%; relief in all symptoms by 64% and over all 
satisfaction 74% and these agree with Lee et al and 
Vilos et al [13, 21] and higher than that of Yen et al 
[22], and this may be explained by smaller sample size 
in his study. While at one year follow up our results 
comparable with Spies et al [23] and Prone et al [24]. 
At two years follow up, there was improvement in 
bleedig by 90.7%, pelvic pressure by 81%, pelvic pain 
by 83%; relief in all symptoms by 88% and over all 
satisfaction 90% and these comparable with Holub et al 
[25]. As regards the operative duration time can not be 
compared with other new technologies used in 
management of symptomatic myomas like MRgFUS, 
UAC, UAL, UAE; myolysis or even temporary uterine 
arteries occlusion which may take from minimally six to 
nine hours [21]. Our study concluded that three cases 
22    International Journal of Gynecology, Obstetrics and Neonatal Care, 2014, Vol. 1, No. 1 Helal et al. 
only had intra operative bladder injury, nine cases 
received NSAID + morphia as post operative 
analgesics and three cases had severe blood loss 
entailing blood transfusion. 
CONCLUSION    
 Trans vaginal bilateral uterine arteries occlusion is 
safe, feasible; simple and an effective alternative 
management of symptomatic uterine myomas in low 
resourse settings leading to improvement in clinical 
symptoms in the majority of patients. 
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